At-home wearables and machine learning capture motor impairment and progression in adult ataxias DOI Creative Commons

Radhika Manohar,

Faye X. Yang,

Christopher D. Stephen

и другие.

medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Окт. 29, 2024

A significant barrier to developing disease-modifying therapies for spinocerebellar ataxias (SCAs) and multiple system atrophy of the cerebellar type (MSA-C) is scarcity tools sensitively measure disease progression in clinical trials. Wearable sensors worn continuously during natural behavior at home have potential produce ecologically valid precise measures motor function by leveraging frequent numerous high-resolution samples behavior. Here we test whether movement-building block characteristics (i.e., submovements), obtained from wrist ankle home, can capture SCAs MSA-C, as recently shown amyotrophic lateral sclerosis (ALS) ataxia telangiectasia (A-T). Remotely collected cross-sectional (

Язык: Английский

Gait characteristics in people with Friedreich ataxia: daily life versus clinic measures DOI Creative Commons
Hannah Casey, Vrutangkumar V. Shah, Daniel Muzyka

и другие.

Frontiers in Neurology, Год журнала: 2025, Номер 16

Опубликована: Март 17, 2025

Gait assessments in a clinical setting may not accurately reflect mobility everyday life. To better understand gait during daily life, we compared measures that discriminated Friedreich ataxia (FRDA) from healthy control (HC) subjects prescribed clinic tests and free, daily-life monitoring. We recruited 9 people with FRDA (median age: 20, IQR [12, 48] years). A comparative subject cohort of was sampled using propensity matching on age 18 [13, 22] Subjects wore 3 inertial sensors (one each foot lower back) the laboratory 2-min walk at natural pace, followed by 7 days For life analysis, total 99,216 strides across 1,008 h recording were included. Mann-Whitney U test area under curve (AUC) differences between HC when assessed Pairwise Wilcoxon also if participants exhibited different metric values two environments. The group levels activity. Measures best characteristics differed Variation elevation feet midswing in-clinic (Clinic AUC = 1, Home 0.69), whereas slow speed performed (Home Clinic 0.64). Of 17 tested, 11 had an > 0.8 8 >0.8 home. Variability swing time 0.97, 0.94) double-support 0.94, most sensitive specific for both Digital are However, more free-living versus gait, suggesting does gait.

Язык: Английский

Процитировано

0

Predictive machine learning and multimodal data to develop highly sensitive, composite biomarkers of disease progression in Friedreich Ataxia DOI
Susmita Saha, Louise A. Corben, Louisa P. Selvadurai

и другие.

Research Square (Research Square), Год журнала: 2025, Номер unknown

Опубликована: Апрель 4, 2025

Abstract Friedreich Ataxia (FRDA) is a rare, inherited progressive movement disorder for which there currently no cure. The field urgently requires more sensitive, objective, and clinically relevant biomarkers to enhance the evaluation of treatment efficacy in clinical trials speed up process drug discovery. This study pioneers development relevant, multidomain, fully objective composite disease severity progression, using multimodal neuroimaging background data (i.e., demographic, history, genetics). Data from 31 individuals with FRDA controls longitudinal natural history IMAGE-FRDA, were included. Using an elasticnet predictive machine learning (ML) regression model, we derived weighted combination background, structural MRI, diffusion quantitative susceptibility imaging (QSM) measures that predicted Rating Scale (FARS) high accuracy (R² = 0.79, root mean square error (RMSE) 13.19). also exhibited strong sensitivity progression over two years (Cohen's d 1.12), outperforming FARS score alone (d 0.88). approach was validated Assessment (SARA), demonstrating potential robustness ML-derived composites surpass individual act as complementary or surrogate markers progression. However, further validation, refinement, integration additional modalities will open new opportunities translating these into practice FRDA, well other rare neurodegenerative diseases.

Язык: Английский

Процитировано

0

At-home wearable-based monitoring predicts clinical measures and biological biomarkers of disease severity in Friedreich’s Ataxia DOI Creative Commons
Ram Kinker Mishra, Adonay S. Nunes,

Ana Enriquez

и другие.

Communications Medicine, Год журнала: 2024, Номер 4(1)

Опубликована: Окт. 29, 2024

Язык: Английский

Процитировано

2

At-home wearables and machine learning capture motor impairment and progression in adult ataxias DOI Creative Commons

Radhika Manohar,

Faye X. Yang,

Christopher D. Stephen

и другие.

medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Окт. 29, 2024

A significant barrier to developing disease-modifying therapies for spinocerebellar ataxias (SCAs) and multiple system atrophy of the cerebellar type (MSA-C) is scarcity tools sensitively measure disease progression in clinical trials. Wearable sensors worn continuously during natural behavior at home have potential produce ecologically valid precise measures motor function by leveraging frequent numerous high-resolution samples behavior. Here we test whether movement-building block characteristics (i.e., submovements), obtained from wrist ankle home, can capture SCAs MSA-C, as recently shown amyotrophic lateral sclerosis (ALS) ataxia telangiectasia (A-T). Remotely collected cross-sectional (

Язык: Английский

Процитировано

1